HELIX ACQUISITION CORP II BBOT
CL A ORD SHS · Common Stock · CUSIP G4444H101
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersSouth San Francisco, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $10.45.
Trends to Q3 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2024 | 30 |
| Q2 2024 | 32 |
| Q3 2024 | 32 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 7 | 3 |
| Q3 2024 | 6 | 5 |
Biggest buyers
| Schonfeld Strategic Advisors LLC | New | +119.9k |
| SILVERARC CAPITAL MANAGEMENT, LLC | Added | +13.4k |
| MILLENNIUM MANAGEMENT LLC | Added | +12.9k |
| ACUTA CAPITAL PARTNERS, LLC | Added | +3.1k |
| CITADEL ADVISORS LLC | Added | +142 |
| UBS Group AG | New | +21 |
Biggest sellers
| Walleye Capital LLC | Sold out | -92.9k |
| Walleye Trading LLC | Sold out | -52.2k |
| COWEN AND COMPANY, LLC | Reduced | -5.5k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | -3.1k |
| T. Rowe Price Investment Management, Inc. | Reduced | -2.4k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Helix Holdings II LLC
13D · may seek influence
filed 2025-03-04
Stated purposeItem 4 is hereby amended and supplemented as follows: On February 8, 2025, in connection with the appointment of Albert A. Holman III to the board of directors of the Issuer, the Sponsor transferred 30,000 Class B ordinary shares held by it to Mr. Holman. As reported by the Issuer on a Current Report on Form 8-K filed on March 3, 2025, on February 28, 2025 (the "Helix 8-K") the Issuer entered into a business combination agreement (the "Business Combination Agreement") by and among the Issuer, Helix II Merger Sub, Inc. ("Merger Sub") and TheRas, Inc. (doing business as BridgeBio Oncology Therapeutics, Inc. "BBOT"). Upon the terms and subject to the conditions of the Business Combination Agreement, (i) Helix will de-register in the Cayman Islands and transfer by way of continuation out of… Full filing |
31.6% |
| Sculptor Capital LP 13G · passive investor new · filed 2025-07-24 | 5.1% |
Insider purchases and sales in Q3 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 1 | $24.0m | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
None reported in Q3 2024.
Holders, Q3 2024
| Manager | Shares | Change |
|---|---|---|
| Cormorant Asset Management, LP 1.61% of their portfolio | 2.9m $30.4m | Unchanged |
| BlackRock, Inc. 0.00% of their portfolio | 1.5m $15.7m | First filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.03% of their portfolio | 1.4m $14.6m | Unchanged |
| CITADEL ADVISORS LLC 0.01% of their portfolio | 1.3m $13.9m | Added +142 |
| MILLENNIUM MANAGEMENT LLC 0.01% of their portfolio | 1.1m $11.8m | Added +12.9k |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 1.1m $11.8m | Reduced -3.1k |
| Sculptor Capital LP 0.15% of their portfolio | 705.0k $7.4m | Unchanged |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.03% of their portfolio | 600.0k $6.3m | Unchanged |
| SILVERARC CAPITAL MANAGEMENT, LLC 1.21% of their portfolio | 513.4k $5.4m | Added +13.4k |
| PERCEPTIVE ADVISORS LLC 0.11% of their portfolio | 500.0k $5.2m | Unchanged |
| GREAT POINT PARTNERS LLC 1.58% of their portfolio | 500.0k $5.2m | Unchanged |
| Commodore Capital LP 0.33% of their portfolio | 500.0k $5.2m | Unchanged |
| SOROS FUND MANAGEMENT LLC 0.10% of their portfolio | 475.0k $5.0m | Unchanged |
| ADAR1 Capital Management, LLC 0.71% of their portfolio | 404.1k $4.2m | Unchanged |
| T. Rowe Price Investment Management, Inc. 0.00% of their portfolio | 397.6k $4.2m | Reduced -2.4k |
| Laurion Capital Management LP 0.20% of their portfolio | 300.0k $3.1m | Unchanged |
| Ghost Tree Capital, LLC 1.14% of their portfolio | 300.0k $3.1m | Unchanged |
| Affinity Asset Advisors, LLC 0.41% of their portfolio | 250.0k $2.6m | Unchanged |
| Octagon Capital Advisors LP 0.42% of their portfolio | 250.0k $2.6m | Unchanged |
| STEMPOINT CAPITAL LP 0.63% of their portfolio | 200.0k $2.1m | Unchanged |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 189.3k $2.0m | Unchanged |
| WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio | 184.7k $1.9m | Unchanged |
| ACUTA CAPITAL PARTNERS, LLC 1.53% of their portfolio | 180.9k $1.9m | Added +3.1k |
| TD Asset Management Inc 0.00% of their portfolio | 144.8k $1.5m | Unchanged |
| Schonfeld Strategic Advisors LLC 0.01% of their portfolio | 119.9k $1.3m | New |
| Woodline Partners LP 0.01% of their portfolio | 103.2k $1.1m | Unchanged |
| MOORE CAPITAL MANAGEMENT, LP 0.03% of their portfolio | 100.0k $1.0m | Unchanged |
| COWEN AND COMPANY, LLC 0.02% of their portfolio | 45.0k $470.7k | Reduced -5.5k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 10.9k $113.6k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 21 $219 | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 8 $84 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |